It was identified that Aβ exposure in an AD murine model elicited robust type-I IFN production in microglia, with the blockade of the receptor IFNAR being able to rescue both memory and synaptic deficits (Roy et al., 2022). This evidence concerns the gene IFNAR1 and Alzheimer disease.